B. Nare, L. J. Hardy, L. Beverley, and S. , New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTRI) as, 1997.

A. Bello, B. Nare, D. Freedman, L. Hardy, and S. Beverley, PTRI: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major, PNAS USA, issue.24, pp.91-11442, 1994.

T. Ellenberger and S. Beverley, Multiple drug resistance and conservative amplification of the H region in Leishmania major, J Biol Chem, vol.264, issue.25, pp.15094-15103, 1989.

B. Papadopulou, G. Roy, and M. Ouellette, A novel antifolate resistance gene on the amplified H circle of Leishmania, EMBO J, vol.11, pp.910-3601, 1992.

R. Arrebola, A. Olmo, P. Reche, E. Garvey, D. Santi et al., Isolation and characterization of a mutant dihydrofolate reductase?thymidylate synthase from methotrexate? resistant Leishmania cells, J Biol Chem, issue.14, pp.269-10590, 1994.

J. Beck and B. Ullman, Biopterin conversion to reduced folates byLeishmania donovani promastigotes, Molecular and Biochemical Parasitology, vol.49, issue.1, pp.21-28, 1991.
DOI : 10.1016/0166-6851(91)90126-Q

D. Govrley, L. J. Hardy, L. Beverley, S. Hunter, and W. , Crystallization of recombinant Leishmania major pterdine reductase 1 (PTRI), Acta Cryst D Biol Crystallogr, pp.55-1608, 1999.

J. Luba, B. Nare, P. Liang, K. Anderson, S. Beverley et al., Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: Stereochemical and kinetic evidence, Biochemistry, issue.12, pp.37-4093, 1998.

B. Nare, L. Hardy, and S. Beverley, The roles of pteridine reductese 1 (PTRI) and dihydrofolate reductase ? thymidylate synthase (DHFR-TS) in pteridine metabolism in the protozoan parasite Leishmania major, J Biol Chem, issue.21, pp.272-13883, 1997.

M. Grogl, T. Thomason, and E. Franke, Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease, Am J Trop Med Hyg, vol.47, issue.1, pp.117-126, 1992.

M. Cunningham and S. Beverley, Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy, Molecular and Biochemical Parasitology, vol.113, issue.2, pp.199-213, 2001.
DOI : 10.1016/S0166-6851(01)00213-4

C. Nichol, G. Smith, and D. Dutch, Biosynthesis and Metabolism of Tetrahydrobiopterin and Molybdopterin, Annual Review of Biochemistry, vol.54, issue.1, 1985.
DOI : 10.1146/annurev.bi.54.070185.003501

F. Kheirandish, . Bandehpour, . Haghighi, . Mahboudi, . Mohebali et al., Molecular Cloning and Expression of Iranian Leishmania major Pteridine Reductase 1, Iranian J Parasitol, vol.3, issue.2, pp.1-9, 2008.

E. Appelbaum and A. Shatzman, Protein expression, a practical approach, pp.169-200, 1999.

J. Sambrook and D. Russell, Molecular cloning . A laboratory manual, pp.4-14, 2001.

P. Kumar, H. Kothari, and N. Singh, Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani, Protein Expression and Purification, vol.38, issue.2, pp.228-264, 2004.
DOI : 10.1016/j.pep.2004.08.015

M. Mohebali, E. Javadian, M. Yaghoobi-ershadi, A. Akhavan, H. Hajaran et al., Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran, East Mediterr Health J, vol.10, pp.4-5, 2004.

M. Mohebali, G. Edrissian, A. Nadim, H. Hajjaran, B. Akhoundi et al., Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in the Islamic Republic of Iran, Iranian J Parasitol, vol.1, issue.1, pp.15-25, 2006.

M. Ouellette, Biochemical and molecular mechanisms of drug resistance in parasites, Tropical Medicine and International Health, vol.244, issue.11, pp.874-876, 2001.
DOI : 10.1016/S0166-6851(97)00215-6

S. Sunder, Drug resistance in Indian visceral leishmaniasis, Tropical Medicine and International Health, vol.793, issue.11, pp.849-855, 2001.
DOI : 10.1086/318122

R. Hadighi, P. Boucher, A. Khamesipour, A. Meamar, G. Roy et al., Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs, Parasitology Research, vol.194, issue.5, pp.1319-1322, 2007.
DOI : 10.1007/s00436-007-0638-0

A. Asilian, T. Jalayer, J. Whitworth, R. Ghasemi, M. Nilforooshzadeh et al., A randomized, placebo, controlled trial of a two-week regimen of aminacidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran, Am J Trop Med Hyg, issue.6, pp.53-648, 1995.

A. Asilian, T. Jalayer, M. Nilforooshzadeh, R. Ghasemi, R. Peto et al., Treatment of cutaneous leishmaniasis with aminosidine (paromomaycin) ointement: double ? blind, randomized trial in the lslamic Republic of Iran, Bulletin WHO, issue.5, pp.81-353, 2003.

A. Coderre, M. Beverley, R. Schinmke, and D. Santi, Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica., Proceedings of the National Academy of Sciences, vol.80, issue.8, pp.2132-2136, 1983.
DOI : 10.1073/pnas.80.8.2132

R. Bello, N. B. Freedman, D. Hardy, L. Beverley, and S. , PTRI: A reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major, Proc Natl Acad Sci, issue.24, pp.91-11442, 1994.

B. Nare, L. Hardy, and S. Beverley, The roles of pteridine reductese 1 and dihydrofolate reductase?thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major, J Biol Chem, issue.21, pp.272-13883, 1997.

M. Cunningham and S. Beverley, Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy, Molecular and Biochemical Parasitology, vol.113, issue.2, pp.199-213, 2001.
DOI : 10.1016/S0166-6851(01)00213-4

R. Wagner, Gene inhibition using antisense oligodeoxynucleotides, Nature, vol.372, issue.6504, pp.33-335, 2002.
DOI : 10.1038/372333a0

V. Mundodi, A. Kucknoor, and L. Gedamu, Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition, BMC Molecular Biology, vol.6, issue.1, p.3, 2005.
DOI : 10.1186/1471-2199-6-3

W. Zhang, X. Chen, and F. Qui, An antisense plasmid targeting surviving expression induces apoptosis and sensitizes hepatocarcinoma cells to chemotherapy, J Huazhong Univ Sci Technology Med Sci, vol.23, issue.4, pp.387-391, 2003.

C. Dumas, C. Chow, M. Muller, and B. Papadopoulou, A Novel Class of Developmentally Regulated Noncoding RNAs in Leishmania, Eukaryotic Cell, vol.5, issue.12, pp.2033-2046, 2006.
DOI : 10.1128/EC.00147-06